TWD 18.1
(-1.9%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -84.99 Million TWD | -318.46% |
2022 | 76.1 Million TWD | 477.05% |
2021 | 13.18 Million TWD | 575.27% |
2020 | 1.95 Million TWD | -77.0% |
2019 | 8.49 Million TWD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -31.84 Million TWD | -61.14% |
2024 Q2 | -31.84 Million TWD | 0.0% |
2023 Q1 | -21.18 Million TWD | -57.49% |
2023 Q4 | -19.76 Million TWD | 0.0% |
2023 FY | -166.24 Million TWD | -318.46% |
2023 Q2 | -21.18 Million TWD | 0.0% |
2023 Q3 | -19.76 Million TWD | 6.71% |
2022 Q3 | -13.45 Million TWD | 0.0% |
2022 FY | 76.1 Million TWD | 477.05% |
2022 Q4 | -13.45 Million TWD | 0.0% |
2021 FY | 13.18 Million TWD | 575.27% |
2020 FY | 1.95 Million TWD | -77.0% |
2019 FY | 8.49 Million TWD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
GeneReach Biotechnology Corp. | -229.28 Million TWD | 62.931% |
Sunmax Biotechnology Co., Ltd. | 894.79 Million TWD | 109.499% |
Lukas Biomedical Inc. | -43.56 Million TWD | -95.119% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 281.85 Million TWD | 130.156% |
Level Biotechnology Inc. | 67.55 Million TWD | 225.82% |
Sagittarius Life Science Corp | -64.37 Million TWD | -32.027% |
NeoCore Technology Co., Ltd. | -84.94 Million TWD | -0.059% |
TaiMed Biologics Inc. | -166.23 Million TWD | 48.87% |
GlycoNex Incorporation | -259.86 Million TWD | 67.293% |
VBI | -16.13 Million TWD | -426.866% |
Taiwan Advance Bio-Pharmaceutical Inc. | -2.25 Million TWD | -3672.481% |
SynCore Biotechnology Co.,Ltd | -45.5 Million TWD | -86.792% |
Visgeneer Inc. | -21.15 Million TWD | -301.692% |
Mycenax Biotech Inc. | -602.1 Million TWD | 85.884% |
G&E Herbal Biotechnology Co., Ltd. | 80.68 Million TWD | 205.342% |
Neith Corporation | -48.85 Million TWD | -73.976% |
TaiwanJ Pharmaceuticals Co., Ltd. | -6.61 Million TWD | -1185.84% |
Enimmune corporation | -243.47 Million TWD | 65.091% |
TaiRx, Inc. | -214.69 Million TWD | 60.412% |
CHO Pharma, Inc. | -268.99 Million TWD | 68.403% |
EirGenix Inc. | -1.03 Billion TWD | 91.764% |
BioLASCO Taiwan Co., Ltd. | 63.33 Million TWD | 234.198% |
Sunny Pharmtech Inc. | -72.09 Million TWD | -17.89% |
Advagene Biopharma Co., Ltd. | -93.33 Million TWD | 8.938% |
BioGend Therapeutics Co., Ltd. | -176.54 Million TWD | 51.856% |
Feng Chi Biotech Corp. | 24.16 Million TWD | 451.767% |
RBC Bioscience Corporation | 14.53 Million TWD | 684.593% |
BiOptic Inc. | 44.05 Million TWD | 292.936% |
Anti-Microbial Savior BioteQ Co., Ltd | -56.74 Million TWD | -49.772% |
BRIM Biotechnology, Inc. | -694.12 Million TWD | 87.755% |
Shine-On BioMedical Co.,Ltd. | -62.68 Million TWD | -35.593% |
Great Novel Therapeutics Biotech & Medicals | -65.81 Million TWD | -29.131% |
Syngen Biotech Co.,Ltd. | 334.08 Million TWD | 125.441% |
Medigen Vaccine Biologics Corporation | -1.21 Billion TWD | 92.998% |
Bio Preventive Medicine Corp. | -70.58 Million TWD | -20.419% |
Lin BioScience, Inc. | -1.09 Billion TWD | 92.251% |
NaviFUS Corp. | -76.42 Million TWD | -11.211% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | -93.95 Million TWD | 9.538% |
Sinew Pharma Inc. | -186.25 Million TWD | 54.366% |
Andros Pharmaceuticals Co.,Ltd | -67.69 Million TWD | -25.551% |
Greenyn Biotechnology Co., Ltd | 159.81 Million TWD | 153.182% |
Lumosa Therapeutics Co., Ltd. | -375.62 Million TWD | 77.373% |
AP Biosciences Inc | -347.47 Million TWD | 75.54% |
Medigen Biotechnology Corp. | -1.23 Billion TWD | 93.107% |
3D Global Biotech Inc. | -62.85 Million TWD | -35.227% |
Pharmosa Biopharm Inc. | -2.82 Million TWD | -2909.703% |
Intech Biopharm Corporation | -304.39 Million TWD | 72.078% |
Oneness Biotech Co., Ltd. | -1.09 Billion TWD | 92.249% |
Eusol Biotech Co.,Ltd. | -41.48 Million TWD | -104.894% |
TWi Biotechnology, Inc. | -169.55 Million TWD | 49.873% |
Ever Supreme Bio Technology Co., Ltd | 337.73 Million TWD | 125.166% |
TCI GENE Inc. | 10.04 Million TWD | 945.796% |
MegaPro Biomedical Co., Ltd | -127.25 Million TWD | 33.211% |
Senhwa Biosciences, Inc. | -311.11 Million TWD | 72.68% |
Taiwan Bio Therapeutics Co., Ltd | -212.2 Million TWD | 59.947% |
NatureWise Biotech & Medicals Corporation | 3.43 Million TWD | 2575.073% |
PharmaEngine, Inc. | 277.18 Million TWD | 130.663% |
Savior Lifetec Corporation | -2.42 Million TWD | -3412.149% |
TaiGen Biopharmaceuticals Holdings Limited | -174.69 Million TWD | 51.348% |
OBI Pharma, Inc. | -2.08 Billion TWD | 95.933% |
Meribank Biotech Co., Ltd | -123.15 Million TWD | 30.986% |
Acepodia, Inc. | -435.97 Million TWD | 80.505% |
Caliway Biopharmaceuticals Co., Ltd. | -487.95 Million TWD | 82.582% |